The COVID-19 pandemic highlighted the importance of genomics in our public health toolkit to prepare for and respond to pathogens with pandemic and epidemic potential. As countries build on the genomic surveillance gains from the COVID-19 pandemic, questions are arising.
Entire content available on:
Language
EnglishTypology
Guidelines/Recommendations/Technical Instructions News and updatesTopic
Covid-19 Surveillance Emerging Diseases Health technology Infectious Diseases PreparednessTarget
Public HealthCountries
USA Canada South America Central America Caribbean Middle East South pacific China India Indochina Singapore Europe & UK Oceania Africa